Therapeutics: Multiple endocrine neoplasia I (menin; MEN1); myeloid-lymphoid or mixed-lineage leukemia (MLL; HRX)

Cell and mouse studies suggest inhibitors of the menin-MLL interaction could help treat prostate cancer. In prostate cancer patients, tumor levels of menin correlated with poor outcomes. In human pros...